Q3 Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Q3 Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,686	Closed	-$4M	–	78
2025 Q4	$4M	Buy	+23,686	New	+$3.85M	0.92%	15
2023 Q1	–	Sell	-11,351	Closed	-$1.49M	–	55
2022 Q4	$1.49M	Sell	11,351 -54	-0.5%	-$6.98K	1.01%	22
2022 Q3	$1.33M	Buy	+11,405	New	+$1.42M	0.97%	24
2021 Q2	–	Sell	-33,485	Closed	-$5.05M	–	49
2021 Q1	$5.05M	Buy	+33,485	New	+$5.32M	2.69%	8
2020 Q1	–	Sell	-4,525	Closed	-$545K	–	34
2019 Q4	$545K	Buy	+4,525	New	+$505K	1.23%	21

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Q3 Asset Management's IBB Position: Q1 2026 in Review

Q3 Asset Management sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 23,686 shares — an estimated $4M sold.

Q3 Asset Management first reported a position in IBB in Q4 2019 and held it in 5 quarters. The position peaked at $5.05M in Q1 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Q3 Asset Management reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
Q3 Asset Management sold 23,686 iShares Biotechnology ETF shares in Q1 2026, an estimated $4M.
Q3 Asset Management first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 5 quarters.
Q3 Asset Management's iShares Biotechnology ETF position peaked at $5.05M in Q1 2021.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Q3 Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.